FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma
Business Wire India The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate® MSI Dx Analysis System as…